Skip to content

Retrospective study on the evaluation of chronic and long-term pain therapeutics to manage post-traumatic cervical dystonia

Effect of Botulinum toxin with physical therapy on patients with post-traumatic cervical dystonia is effective to manage long-term, chronic pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN32597955
Enrollment
20
Registered
2017-04-07
Start date
2016-01-25
Completion date
Unknown
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-traumatic cervical dystonia Musculoskeletal Diseases Post-traumatic cervical dystonia

Interventions

All participants have been diagnosed with cervical dystonia caused after trauma from a motor vehicle accident. They receive care as usual in the emergency room and from a primary care physician, who p

Sponsors

Advanced Pain Specialists, PLLC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Soft tissue injury resulting in cervical dystonia neck distortion following a motor vehicle accident 2. Range of motion limited to laterocollis and shoulder elevation 3. Experienced neck pain after trauma and were prescribed physical therapy either opioids or NSAIDs 4. Pain symptoms lasting 14 – 16 weeks from initial trauma 5. Patients attended 3 physical therapy sessions per week 6. Toronto Western Spasmodic Torticollis Rating Scale (TWISTRS) greater than 35 7. Visual analogue scale (VAS) score greater than 7 8. Presence of hernia on magnetic resonance imaging (MRI) 9. Aged 18 years and over

Exclusion criteria

Exclusion criteria: 1. Patients solely on muscle relaxer medication to relieve pain 2. Less than 18 years of age 3. Pregnancy or breast feeding 4. Diagnosed neuromuscular disorders 5. Previous use of botulinum toxin

Design outcomes

Primary

MeasureTime frame
Pain, as measured using the visual analogue scale at baseline, within 6 weeks and within 90 days weeks of receiving botulinum toxin and assessed through medical record review.

Secondary

MeasureTime frame
Range of motion, as measured by physical examination at baseline, within 6 weeks and within 90 days weeks of receiving botulinum toxin and assessed through medical record review.

Countries

United States of America

Contacts

Public ContactRicardo Borrego

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026